Determinants of the Cancer Drug Funding Process in Canada.
Background: Canada has a publicly funded healthcare system with a complex drug funding process. After Health Canada approval to market a drug, the pan-Canadian Oncology Drug Review (pCODR) (now renamed the CADTH reimbursement review) makes a non-binding funding recommendation to the Canadian provinc...
| Publicado en: | Current Oncology Vol. 29; no. 3; pp. 1997 - 2008 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
MDPI
Mar2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |